Cardiac biomarkers stand as crucial elements in the landscape of cardiovascular medicine, providing indispensable information about heart health. These biomarkers, often identifiable proteins released into the bloodstream in response to specific cardiac events, are instrumental in the diagnosis, prognosis, and ongoing monitoring of various cardiovascular conditions. While troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) remain prominent players in this domain, ongoing research strives to unveil new biomarkers that can offer even more nuanced insights into heart function. The continuous evolution of cardiac biomarker research contributes to a deeper understanding of cardiovascular diseases, paving the way for innovative diagnostic tools and personalized treatment approaches. As healthcare professionals delve into expanding the repertoire of cardiac biomarkers, they aim to enhance the precision of diagnoses and ultimately improve patient outcomes in the realm of cardiovascular care.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom